Molecule of the month. Riociguat.
D002985:Clinical Protocols; D017326:Clinical Trials, Phase III as Topic; D020536:Enzyme Activators / Q000627:therapeutic use; D006162:Guanylate Cyclase / Q000096:biosynthesis*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D015394:Molecular Structure; D011655:Pulmonary Embolism / Q000150:complications; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D020536:Enzyme Activators; D011720:Pyrazoles; D011743:Pyrimidines; D006162:Guanylate Cyclase; C542595:riociguat